Exopeptidases remove the terminal amino acids from the protein chain and endopeptidases attack an internal peptide bond, as in trypsin, chymotrypsin, pepsin, elastase and papain. The BRCC36 ...

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...